Catch me if you can: how AML and its niche escape immunotherapy
In spite of the remarkable progress in basic and preclinical studies of acute myeloid
leukemia (AML), the five-year survival rate of AML patients remains poor, highlighting the …
leukemia (AML), the five-year survival rate of AML patients remains poor, highlighting the …
Caveolae: structure, function, and relationship to disease
RG Parton - Annual review of cell and developmental biology, 2018 - annualreviews.org
The plasma membrane of eukaryotic cells is not a simple sheet of lipids and proteins but is
differentiated into subdomains with crucial functions. Caveolae, small pits in the plasma …
differentiated into subdomains with crucial functions. Caveolae, small pits in the plasma …
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease
AT Argaw, L Asp, J Zhang… - The Journal of …, 2012 - Am Soc Clin Investig
In inflammatory CNS conditions such as multiple sclerosis (MS), current options to treat
clinical relapse are limited, and more selective agents are needed. Disruption of the blood …
clinical relapse are limited, and more selective agents are needed. Disruption of the blood …
Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia
The biological and clinical behaviors of hematological malignancies can be influenced by
the active crosstalk with an altered bone marrow (BM) microenvironment. In the present …
the active crosstalk with an altered bone marrow (BM) microenvironment. In the present …
Vascular endothelial growth factor: basic science and clinical progress
N Ferrara - Endocrine reviews, 2004 - academic.oup.com
Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen in vitro and
an angiogenic inducer in a variety of in vivo models. Hypoxia has been shown to be a major …
an angiogenic inducer in a variety of in vivo models. Hypoxia has been shown to be a major …
The role of nitric oxide in tumour progression
D Fukumura, S Kashiwagi, RK Jain - Nature Reviews Cancer, 2006 - nature.com
Nitric oxide (NO) and nitric oxide synthases are ubiquitous in malignant tumours and are
known to exert both pro-and anti-tumour effects. We summarize our current understanding of …
known to exert both pro-and anti-tumour effects. We summarize our current understanding of …
[HTML][HTML] Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis
Mechanotransduction is a key determinant of tissue homeostasis and tumor progression. It is
driven by intercellular adhesions, cell contractility, and forces generated within the …
driven by intercellular adhesions, cell contractility, and forces generated within the …
[HTML][HTML] Role of cholesterol in the development and progression of breast cancer
G Llaverias, C Danilo, I Mercier, K Daumer… - The American journal of …, 2011 - Elsevier
Diet and obesity are important risk factors for cancer development. Many studies have
suggested an important role for several dietary nutrients in the progression and …
suggested an important role for several dietary nutrients in the progression and …
Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities
Nitric oxide (NO) is a pleiotropic molecule critical to a number of physiological and
pathological processes. The last decade has witnessed major advances in dissecting NO …
pathological processes. The last decade has witnessed major advances in dissecting NO …
Caveolin-1 in oncogenic transformation, cancer, and metastasis
TM Williams, MP Lisanti - American Journal of Physiology …, 2005 - journals.physiology.org
Caveolae are 50-to 100-nm omega-shaped invaginations of the plasma membrane that
function as regulators of signal transduction. Caveolins are a class of oligomeric structural …
function as regulators of signal transduction. Caveolins are a class of oligomeric structural …